Subscribe To

Price Alert Latest News Economic Calendar News

WGS / GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023

STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the fourth quarter and full year of 2022 after the market closes on Tuesday, March 14, 2023. On the same day, Katherine Stueland, Chief Executive Officer of GeneDx, and Kevin Feeley, Chief Financial Officer of GeneDx, will host a conference call to discuss financial and operating results at 4:30 p.m. Eastern Time. Read More

Demo Live Account See Partner Details

Content Topics

Genedx

Report

Fourth

Quarter

Full

Year

2022

Financial

Results

Tuesday

Stock

WGS

Posted: Feb 21 2023, 16:30

Author Name: GlobeNewsWire

WGS News

By Seeking Alpha
November 4, 2023

GeneDx Holdings Corp. (WGS) Q3 2023 Earnings Call Transcript

GeneDx Holdings Corp. (NASDAQ:WGS ) Q3 2023 Results Conference Call October 30, 2023 4:30 PM ET Company Participants Sabrina Dunbar - Chief of Staff K

By Seeking Alpha
August 12, 2023

GeneDx Holdings Corp. (WGS) Q2 2023 Earnings Call Transcript

GeneDx Holdings Corp. (NASDAQ:WGS ) Q2 2023 Results Conference Call August 8, 2023 4:30 PM ET Company Participants Tricia Truehart - Head, IR Katherin

By Seeking Alpha
May 14, 2023

GeneDx Holdings Corp. (WGS) Q1 2023 Earnings Call Transcript

GeneDx Holdings Corp. (NASDAQ:WGS ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 AM ET Company Participants Tricia Truehart - Head Investor Relat

By The Motley Fool
April 28, 2023

Why GeneDx Holdings Stock Lagged the Market Today

The genetic-testing specialist is effecting a reverse stock split. Although fully expected, this still wasn't encouraging news for shareholders.

By The Motley Fool
March 22, 2023

Why Shares of GeneDx Dropped Wednesday

GeneDx changed its name from Sema4 in January. The company focuses on genetic testing to better inform healthcare decisions.

By InvestorPlace
March 18, 2023

The 7 Worst Stocks to Buy Now

Generally, I dislike writing about the worst stocks to buy now (or similar themes) because it invariably offends members of the internet defense leagu

By PennyStocks
February 28, 2023

Penny Stocks To Buy Now? 7 Under $5 To Watch Before Next Week

Cheap penny stocks to watch before next week. The post Penny Stocks To Buy Now?

By GlobeNewsWire
February 21, 2023

GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023

STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.